JP2008516909A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008516909A5 JP2008516909A5 JP2007536082A JP2007536082A JP2008516909A5 JP 2008516909 A5 JP2008516909 A5 JP 2008516909A5 JP 2007536082 A JP2007536082 A JP 2007536082A JP 2007536082 A JP2007536082 A JP 2007536082A JP 2008516909 A5 JP2008516909 A5 JP 2008516909A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- disease
- symptoms
- symptom
- receptor agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CC(C(c(cc1)ccc1O)O)NCCc(c(*)c1)cc(*)c1OCC(*)=O Chemical compound CC(C(c(cc1)ccc1O)O)NCCc(c(*)c1)cc(*)c1OCC(*)=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004050952A DE102004050952A1 (de) | 2004-10-18 | 2004-10-18 | Pharmazeutische Zusammensetzung zur Behandlung von Beschwerden, die mit krankhaften Veränderungen oder Irritationen der Prostata verbunden sind |
| US62459004P | 2004-11-03 | 2004-11-03 | |
| PCT/EP2005/010975 WO2006042679A1 (de) | 2004-10-18 | 2005-10-12 | Verwendung eines beta-3-agonisten zur behandlung von beschwerden der prostata und des unteren urogenitaltrakts |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008516909A JP2008516909A (ja) | 2008-05-22 |
| JP2008516909A5 true JP2008516909A5 (https=) | 2008-11-27 |
Family
ID=36202691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007536082A Pending JP2008516909A (ja) | 2004-10-18 | 2005-10-12 | 前立腺及び下部泌尿生殖路の病気を治療するためのβ−３アゴニストの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060084700A1 (https=) |
| EP (1) | EP1804778A1 (https=) |
| JP (1) | JP2008516909A (https=) |
| CA (1) | CA2580170A1 (https=) |
| TW (1) | TW200630083A (https=) |
| WO (1) | WO2006042679A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
| UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
| CA2630818A1 (en) * | 2005-11-28 | 2007-05-31 | Kissei Pharmaceutical Co., Ltd. | Pharmaceutical composition for prevention or treatment of neurogenic pain |
| EP2037927B1 (en) * | 2006-06-30 | 2010-01-27 | Boehringer Ingelheim International GmbH | Flibanserin for the treatment of urinary incontinence and related diseases |
| AU2008233232A1 (en) * | 2007-03-29 | 2008-10-09 | Merck Sharp & Dohme Corp. | Combination therapy for the treatment-of lower urinary tract symptoms |
| WO2011043942A1 (en) * | 2009-10-07 | 2011-04-14 | Merck Sharp & Dohme Corp. | Combination therapy using a beta 3 adrenergic receptor agonist and an antimuscarinic agent |
| US9522129B2 (en) | 2010-08-03 | 2016-12-20 | Velicept Therapeutics, Inc. | Pharmaceutical Combination |
| AU2011285928B9 (en) * | 2010-08-03 | 2018-08-02 | B3Ar Therapeutics, Inc. | Combinations of beta - 3 adrenergic receptor agonists and muscarinic receptor antagonists for treating overactive bladder |
| US9907767B2 (en) | 2010-08-03 | 2018-03-06 | Velicept Therapeutics, Inc. | Pharmaceutical compositions and the treatment of overactive bladder |
| HK1245117A1 (zh) | 2014-12-03 | 2018-08-24 | Velicept Therapeutics, Inc. | 使用调节释放索拉贝隆用於下尿路症状的组合物和方法 |
| ES2967863T3 (es) | 2015-10-23 | 2024-05-06 | B3Ar Therapeutics Inc | Ion dipolar de solabegron y usos del mismo |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5116615A (en) * | 1989-01-27 | 1992-05-26 | Immunolytics, Inc. | Method for treating benign prostatic hypertrophy |
| MY126489A (en) * | 1998-07-08 | 2006-10-31 | Kissei Pharmaceutical | Phenoxyacetic acid derivatives and medicinal compositions containing the same |
| UA77000C2 (en) * | 2001-09-13 | 2006-10-16 | Kissei Pharmaceutical | Crystalline form of hydroxynorephedrine derivative |
| DE10251170A1 (de) * | 2002-10-31 | 2004-05-13 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| EP1424079A1 (en) * | 2002-11-27 | 2004-06-02 | Boehringer Ingelheim International GmbH | Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine |
| JP2006522144A (ja) * | 2003-04-04 | 2006-09-28 | ダイノゲン ファーマシューティカルズ，インコーポレイテッド | 下部尿路障害の治療方法 |
| US20050222247A1 (en) * | 2003-12-13 | 2005-10-06 | Bayer Healthcare Ag | Chroman derivatives |
-
2005
- 2005-10-12 CA CA002580170A patent/CA2580170A1/en not_active Abandoned
- 2005-10-12 JP JP2007536082A patent/JP2008516909A/ja active Pending
- 2005-10-12 WO PCT/EP2005/010975 patent/WO2006042679A1/de not_active Ceased
- 2005-10-12 EP EP05799213A patent/EP1804778A1/de not_active Withdrawn
- 2005-10-17 TW TW094136193A patent/TW200630083A/zh unknown
- 2005-10-18 US US11/252,838 patent/US20060084700A1/en not_active Abandoned